| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
42,587 |
38,617 |
$489K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,409 |
21,298 |
$203K |
| 36415 |
Collection of venous blood by venipuncture |
37,369 |
35,087 |
$123K |
| 99215 |
Prolong outpt/office vis |
10,950 |
10,372 |
$115K |
| 90686 |
|
3,850 |
3,238 |
$76K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,120 |
3,003 |
$73K |
| 90688 |
|
2,549 |
2,430 |
$45K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,629 |
7,265 |
$38K |
| 0011A |
|
815 |
815 |
$32K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,267 |
1,992 |
$32K |
| 0012A |
|
791 |
791 |
$31K |
| 90670 |
|
1,278 |
1,144 |
$30K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,629 |
1,550 |
$29K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,284 |
3,098 |
$26K |
| 99173 |
|
8,733 |
8,259 |
$23K |
| 0064A |
|
408 |
390 |
$22K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
531 |
482 |
$21K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,530 |
2,417 |
$19K |
| 90698 |
|
680 |
675 |
$16K |
| 0071A |
|
221 |
219 |
$14K |
| 0001A |
|
299 |
298 |
$13K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
778 |
752 |
$11K |
| 90651 |
|
505 |
426 |
$11K |
| 71046 |
Radiologic examination, chest; 2 views |
411 |
386 |
$11K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
457 |
453 |
$11K |
| 90633 |
|
421 |
414 |
$10K |
| 0072A |
|
130 |
130 |
$9K |
| 0002A |
|
195 |
195 |
$8K |
| 92551 |
|
8,775 |
8,288 |
$7K |
| 90697 |
|
318 |
303 |
$7K |
| 0134A |
|
238 |
209 |
$7K |
| 90658 |
|
384 |
383 |
$7K |
| 90734 |
|
245 |
242 |
$6K |
| 90680 |
|
246 |
243 |
$6K |
| 90620 |
|
201 |
190 |
$5K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
604 |
557 |
$4K |
| 90710 |
|
183 |
175 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
172 |
158 |
$4K |
| 91322 |
|
54 |
54 |
$4K |
| 90732 |
|
30 |
30 |
$4K |
| 90744 |
|
154 |
154 |
$4K |
| 90480 |
|
114 |
113 |
$3K |
| 90750 |
|
19 |
19 |
$3K |
| 90715 |
|
100 |
96 |
$3K |
| 0124A |
|
75 |
67 |
$3K |
| 0054A |
|
55 |
55 |
$3K |
| 0004A |
|
42 |
42 |
$3K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
846 |
768 |
$2K |
| 90619 |
|
105 |
103 |
$2K |
| 90656 |
|
107 |
107 |
$2K |
| 0013A |
|
26 |
26 |
$2K |
| 73562 |
|
43 |
40 |
$2K |
| 91320 |
|
12 |
12 |
$2K |
| 99205 |
Prolong outpt/office vis |
42 |
42 |
$1K |
| 90756 |
|
63 |
63 |
$1K |
| 90671 |
|
58 |
58 |
$1K |
| 90696 |
|
57 |
57 |
$1K |
| 36416 |
|
351 |
333 |
$996.71 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
308 |
284 |
$967.40 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
186 |
181 |
$935.15 |
| 90694 |
|
174 |
157 |
$823.31 |
| 73560 |
|
31 |
29 |
$797.03 |
| 90662 |
|
90 |
90 |
$541.37 |
| 0074A |
|
13 |
13 |
$520.00 |
| 90647 |
|
18 |
18 |
$419.04 |
| 90716 |
|
15 |
15 |
$349.20 |
| 90723 |
|
15 |
15 |
$349.20 |
| 88150 |
|
476 |
440 |
$338.04 |
| 90677 |
|
14 |
14 |
$330.10 |
| 93000 |
|
376 |
360 |
$292.13 |
| 90707 |
|
12 |
12 |
$279.36 |
| 84702 |
|
37 |
37 |
$248.32 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
562 |
549 |
$84.06 |
| 90661 |
|
87 |
86 |
$46.56 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
535 |
508 |
$13.80 |
| 90653 |
|
22 |
22 |
$1.16 |
| 91313 |
|
159 |
147 |
$0.01 |
| 91300 |
|
852 |
811 |
$0.00 |
| 91312 |
|
74 |
67 |
$0.00 |
| 91301 |
|
1,823 |
1,813 |
$0.00 |
| 91305 |
|
215 |
212 |
$0.00 |
| 91307 |
|
517 |
465 |
$0.00 |
| 91306 |
|
353 |
353 |
$0.00 |